FDA Drug recall D-0488-2015
Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg, 90-count bottles, Rx only, Manufactured by: Watson Lab…
- FDA Drug
- Class III
- terminated
- Published 2015-04-22
On 2015-04-22 the FDA classified a Class III recall of Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg, 90-count bottles, Rx only, Manufactured by: Watson Lab… by Actavis Laboratories Fl, citing presence of Foreign Substance; fine residue or dust identified as aluminum may be on exterior of the capsule shell.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0488-2015 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2015-03-26 |
| Published | 2015-04-22 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Actavis Laboratories Fl |
| Distribution | US |
Product
Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg, 90-count bottles, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA --- NDC 62037-0600-90
Reason
Presence of Foreign Substance; fine residue or dust identified as aluminum may be on exterior of the capsule shell
Identifiers
| upc | 362037600906 |
|---|---|
| code_info | Lot # 956000M, Exp. Aug 2016; UPC 3-6203760090-6 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0488-2015%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.